Share >  
Share
Share on Tumblr

Sun Pharmaceuticals Ltd

News »

   latest by relevance
Capacity debottlenecking led to growth: Shasun Pharma
May 25, 2012 at 15:54 | Source: CNBC-TV18
Abhaya Kumar, managing director, Shasun Pharmaceuticals Ltd says that capacity debottlenecking and higher customer demand contributed to 40% y-o-y growth. He also says that the company expects 25% growth in EPS of the company in FY13.
Taro Q4 net income jumps 84% to USD 47.3 mn
May 25, 2012 at 09:17 | Source: Moneycontrol.com
Taro, a subsidiary of Sun Pharma, showed good growth in January-March quarter of 2012 on year-on-year basis, but there was dip in margins sequentially.
Dr Reddy's, Aurobindo get US nod for generic cardiac drug
May 18, 2012 at 12:58 | Source: Moneycontrol.com
Dr Reddy's Laboratories and Aurobindo Pharma have received US Food and Drugs Administration (FDA) approval to sell a generic version of Clopidogrel tablets, the two companies said on Friday.
Lupin launches Generic Combivir tablets
May 16, 2012 at 12:41 | Source: Moneycontrol.com
Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. has received final approval for its Lamivudine and Zidovudine Tablets, 150 mg/300 mg. from the United States Food and Drugs Administration (FDA). Lupin has already commenced shipping the product.
Sun Pharma Adv Mar '12 sales at Rs 4.22 crore
May 03, 2012 at 20:20 | Source: Moneycontrol.com
Sun Pharma Advanced Research Company has reported a sales turnover of Rs 4.22 crore and a net loss of Rs 21.58 crore for the quarter ended Mar '12
Sell Sun Pharma: Shrikant Chauhan
Apr 27, 2012 at 16:13 | Source: CNBC-Awaaz
Shrikant Chauhan of Kotak Securities feels that one should sell Sun Pharma.

Videos »
Capacity debottlenecking led to growth: Shasun Pharma
Buy Sun Pharma: Sudarshan Sukhani
Sun Pharma can test Rs 650-700: Sukhani
Sell Biocon on rally: Amit Harchekar
Salil Sharma's view on Lupin, Sun Pharma
more »

Photos »

  /  
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

107814 Followers

Other Market Topics  

New Delhi: French drug maker Sanofi on Monday said a US court has rule...

6.55 PM Sep 20th 2011

Web Messenger

Platinum Member

107814 Followers

Other Market Topics  

New Delhi: French drug maker Sanofi on Monday said a US court has rule...

6.40 PM Sep 20th 2011

Web Messenger

Platinum Member

107814 Followers

Sun Pharma  

French drugmaker Sanofi today said a US court has ruled in its favour ...

9.04 AM Sep 23rd 2011

Related News »
Four Indian drug makers get US nod to launch generic version of Plavix
Four Indian drug makers — Dr Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Aurobindo Pharma Ltd — have received approval from the US Food and Drug Administration (USFDA) to launch a low-cost version of ...
May 18, 2012 at 19:25 | Source: Business Standard
DRL launches Plavix copy in US with exclusivity
Mumbai: Drug maker Dr Reddy’s Laboratories Ltd (DRL) said on Friday that it had launched ... and Drug Administration’s approval for the generic version along with Gate Pharmaceuticals, Mylan Inc and Teva Pharmaceuticals. It has been allowed a 180 ...
May 18, 2012 at 09:09 | Source: Livemint.com
Other News To Note
Mylan Pharmaceuticals Inc.andTeva Pharmaceuticals Industries Ltd. received FDA approval for 300 mg clopidogrel, and Apotex Corp., Aurobindo Pharma Ltd., Mylan, Roxane Laboratories, Sun Pharma, Teva and Torrent Pharmaceuticals Ltd. received ...
May 18, 2012 at 01:39 | Source: TMCnet
FDA approves Teva's generic version of blood thinner Plavix
Teva, Mylan Inc. (NYSE: MYL), Apotex Corporation, Roxane Laboratories Inc. of the US, India's Sun Pharmaceutical Industries Ltd. (BSE: 524715) Aurobindo Pharma Ltd. (BSE: 524804) and Torrent Pharmaceuticals, obtained marketing approval for 75 milligram ...
May 20, 2012 at 09:36 | Source: Globes - Israel Business Arena
FDA Approves Generic Versions Of Clot-buster Plavix
News ) and Teva Pharmaceutical Industries Ltd. (TEVA: News )are the companies that have gained FDA approval for 300 milligram Clopidogrel. Apotex Corp., Aurobindo Pharma, Mylan Pharmaceuticals, Roxane Laboratories, Sun Pharma, Teva Pharmaceuticals ...
May 18, 2012 at 04:02 | Source: RTT News
Search Results sun pharma
Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Aurobindo Pharma Ltd — have received approval from the US Food and Drug Administration (USFDA) to launch a low-cost version of blood-thinning drug Plavix in the US. The drug is used to ...
May 19, 2012 at 12:50 | Source: Business Standard
IIP data shocker, Sensex down 127 points
In percentage terms key losers were Tata Power Company Ltd (NSE: TATAPOWER), Ranbaxy Laboratories Ltd (NSE: RANBAXY) and Sun Pharmaceuticals Industries Ltd (NSE: SUNPHARMA) while key gainers were Jaiprakash Associates Ltd (NSE: JPASSOCIAT ...
May 11, 2012 at 11:19 | Source: Commodity Online
Compulsory licensing sets off a wave of price cuts in cancer drugs
before the country reintroduced its product patent regime on pharmaceuticals. Copies of the medicine sold by local drug makers, including Natco, Cipla, Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd, are available at Rs9,000-11,000 for a mo ...
May 8, 2012 at 18:04 | Source: Livemint.com
Indian stocks to watch-May 25
Crompton Greaves , Sun TV, Gujarat Mineral Development Corporation. * India's foreign reserves data (1230 GMT) INDIAN STOCKS TO WATCH EARNINGS * Novelis, the U.S. unit of India's largest aluminum producer HindalCo Industries Ltd, posted a ...
May 25, 2012 at 03:18 | Source: Reuters
HBA Global Announces Finalists for the Beauty Industry's 2012 International Package Design Awards (IPDA)
Ltd. o Socializer's Can You Keep A Secret? Lip Exfoliator & Conditioning Balm by Elizabeth Grant Skin Care; submitted by Elizabeth Grant Skin Care o Stila Dream Catcher Palette by Stila; submitted by Stila FRAGRANCE MASS o Embleme Fragrance ...
May 14, 2012 at 23:55 | Source: Bloomberg

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window